Wednesday, 9 November 2016

Novartis, Pfizer cut prices to win UK approval for cancer drugs

LONDON (Reuters) - Novartis and Pfizer have won approval for two cancer drugs to be used routinely on Britain's National Health Service after offering bigger price discounts.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)